Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
JULY 2022LIFE SCIENCES REVIEW5Roman Mathaes, Head of Pharmaceutical Services andCristina Grigore, Technical Proposal Manager, LonzaRobert J. Prill, Artificial Intelligence Director, Data Science, Ferring PharmaceuticalsPartnering with a CDMO for successful late phase biologic drug product development and launchChallenges and Opportunities for AI in Drug DiscoveryChallenges to Clinical System in China30CXO INSIGHTSLAST WORD082826242018Marc Lacey, Global Pandemic Head, SeqirusMing Li, Director, Bioanalytical and Biomarker Outsourcing Operations, Alexion PharmaceuticalsWayne Hull, Chief Digital & Technology Officer, PCI Pharma ServicesCheryl Chen, Director of Clinical Operations, BeiGene (SHA: 688235)Marianthi Psaha, Global Head of Cell and & Gene Therapy, Santen (TYO: 4536)Grappling with Unpredictability: The Art and Science of Pandemic PreparednessOn Accelerating Bioanalytical Workflow AutomationDriving Digital Transformation in the Pharma IndustryHow we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical CompanyIN MY OPINION
< Page 4 | Page 6 >